The term “global health” has emerged as part of the larger political and historical process, replacing the term “international health” to imply a shared global responsibility for health and is also associated with the growing number and increased roles of other actors beyond governments. In September 2009, Director-General of WHO, in consul

Highlights Economic evidence (cost-effectiveness information) can be used to inform policy-making process in supporting the movement towards universal health coverage. Published literature has focused on methods to set a cost-effectiveness threshold (CET) which can be used to guide the cost-eff

Abstract Background and Objectives The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m

Abstract Background and Objectives The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m

The Association of Southeast Asian Nations (ASEAN) region is characterised by diversity. Progress towards Universal Health Coverage (UHC) and institutionalisation of priority setting through Health Technology Assessment (HTA) is varied and is dependent on several country-specific factors such as the proportion of public investment in health, politi

HITAP team facilitated a two and a half day workshop in Kathmandu, Nepal on March 30 – April 1, 2015 at the request of the Nepalese Ministry of Health and Population (MoHP). The goal of the workshop was to explore the potential application of health and technology assessment (HTA) to evaluate and in

Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading all sectors to acknowledge its significance in enhancing efficiency, fairness, and societal development. These open data movements observed during

The study aims to explore how the processes to assess the appropriateness of health technologies are managed and arried out in responsible organizations in other countries. Health technology assessment institutes in 10 countries, amely England, Germany, the Netherlands, Sweden, Denmark, the USA, Canada, Australia, Republic of Korea, and South Afric

Kinanti Khansa Chavarina is an Associate at the International Unit of the Health Intervention and Technology Assessment Program (HITAP) Foundation in Thailand. Her work focuses on health policy and systems research, such as scoping and systematic reviews, qualitative analysis, and economic evaluation. Her research interests include health policy, h

The abundance of various innovations in healthcare (pharmaceuticals, medical devices, interventions, individual and community health promotion and disease prevention as well as a social health policy) have been continuously used in the healthcare system, resulting in a higher demand for resources and budgets in disease prevention and healthcare. Th